In this study, we reported a novel anti-CEACAM5 mAb CC4, which has striking capabilities of both targeting and accumulating in tumor tissues in vivo and remarkable functions of inhibiting tumor growth in animal models. The gene discussed is CEACAM5; the disease is neoplasm.